ALTIMMUNE, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ALTIMMUNE, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $180.76M, a 377.92% increase year-over-year.
- ALTIMMUNE, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $8.74M, a 74.84% decline year-over-year.
- ALTIMMUNE, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $39.52M.
- ALTIMMUNE, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $37.82M.
- ALTIMMUNE, INC. stock issued during period, value, new issues for fiscal 2025 was $173.73M, a 1638.37% increase from fiscal 2024.
- ALTIMMUNE, INC. stock issued during period, value, new issues for fiscal 2024 was $9.99M, a 88.46% decline from fiscal 2023.
- ALTIMMUNE, INC. stock issued during period, value, new issues for fiscal 2023 was $86.60M, a 54.19% increase from fiscal 2022.
- ALTIMMUNE, INC. stock issued during period, value, new issues for fiscal 2022 was $56.17M, a 13.34% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $180.76M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $8.74M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $173.73M 10-K · filed 2026-03-06 | |
| 2025-09-30 | $39.52M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $37.82M 10-Q · filed 2025-11-06 | |
| 2025-03-31 | $34.75M 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $9.99M 10-K · filed 2026-03-06 | |
| 2023-12-31 | $86.60M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $510.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $13.35M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $56.17M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $31.83M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $21.35M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $2.99M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $64.81M 10-K · filed 2023-02-28 | |
| 2021-06-30 | $18.18M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $34.18M 10-Q · filed 2022-11-10 | |
| 2020-09-30 | $2.83M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $12.67M 10-K · filed 2020-03-27 | |
| 2019-03-31 | $12.67M 10-Q · filed 2020-05-13 | |
| 2018-12-31 | $22.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $26.74M 10-K · filed 2020-03-27 |
| 2014-12-31 | $17.69M 10-K · filed 2017-03-14 | |
| 2013-12-31 | $5.94M 10-K · filed 2016-03-11 | |
| 2011-12-31 | $5.07M 10-K · filed 2014-03-11 | |
| 2010-12-31 | $19.47M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |